Genfleet Therapeutics (Shanghai) Inc Sustainability Reports
GenFleet Therapeutics (Shanghai) Inc. is a clinical-stage biopharmaceutical company focusing on cutting-edge therapies in oncology and immunology. The company builds an integrated R&D platform to develop innovative drug discovery programs targeting novel biological pathways.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 836800OP0710UUAGDU40
FIGI: BBG01X603B56
2 reports from 2025 to 2025
